Musi waChikumi 16-17, 2023, MedGence yakapinda muMusangano wePamusoro-Unhu Hwekusimudzira Hutano hweIndasitiri & iyo 8th Summit yeChina Pharmaceutical R&D Innovation, iyo yakaitwa zvakabudirira muChongqing.
MedGence yakaremekedzwa seimwe ye "2023 Pamusoro 20 R&D CRO Enterprises muChina"!
Chekutanga pane zvese, pamutambo wekuvhura, iyo "2022 China Pharmaceutical R&D Simba Chinzvimbo" yakaburitswa uye MedGence yakaremekedzwa seimwe ye "2023 yepamusoro 20 Pharmaceutical CRO Enterprises muChina"!
Iyo "2023 Pharmaceutical CRO Enterprises muChina" yakasarudzwa neCRO Ranking Nyanzvi Yekuongorora Komiti yakavakirwa pazviratidzo gumi uye zviyero zvakawanda, senge mari yegore rose (mari yekushanda), kukura kwemari yegore (%), purofiti, kukura kwepurofiti (%), R&D investimendi, R&D investimendi kukura (%), saizi yevashandi, kukura kwevashandi ( vhoti yehutungamiriri, hutungamiri hweMG, uye chibodzwa chevashandi. kambani inotungamira imwe-inomira TCM itsva yekugadzira mishonga, yakahwina mubairo "2023 Top 20 Pharmaceutical CRO Enterprises muChina", yakaratidza kugona kwayo uye simba.
Panguva ino, semutungamiri weTCM CXO, Dr. Yi Yueneng, Sachigaro & General maneja weMedGence, akakokwa kuti apinde Musangano weChisere weChina Pharmaceutical R&D Innovation uye akapa hurukuro pa "Kutanga kubva Kumagumo - Strategies Yekuvandudza kweNew Chinese Medicine". Akataura kuti pari zvino, dhizaini yepamusoro-soro yekuvandudzwa kwemishonga yeChinese yakakwidziridzwa nekuvandudzwa, nharaunda yepolicy yakaramba ichigadziridzwa uye rutsigiro rwakawedzerwa, uye mushonga weChinese waunza zera regoridhe. Akarongawo mamiriro emitemo, kutsvagisa nekusimudzira maitiro, uye mamiriro ekushandiswa kwekusimudzira indasitiri yechinyakare yemishonga yeChinese munguva itsva, akaratidza hukama hwemukati, akaongorora matambudziko akamira aripo mukusimukira kwazvino kweindasitiri yemishonga yechinyakare yeChina, uye akakurudzira nzira dzinogoneka.
Zvadaro, Dr. Yi Yueneng, semuiti weforum yakatenderedzwa pa "Is the Spring of Chinese Medicine New Product R&D Coming", vakabatana vakakurukura mafambiro nematambudziko eR&D uye kuvandudzwa kwemishonga yeChinese nevatambi veindasitiri. Semurongi mukuru wemubatanidzwa, MedGence yagara yakadzika midzi muindasitiri yemishonga, ichiongorora nekushingaira, ichigara ichivandudza, ichikurudzira kusimukira kweindasitiri, uye kuramba ichishandira makambani emishonga akatenderedza China.
Musangano uyu wakakwezva vatungamiriri vazhinji mundima yemutemo wemishonga, makoreji nemayunivhesiti, masangano ekutsvagisa, makambani emishonga, maR & D mayuniti uye mamwe akawanda evakuru kuti vatore chikamu mumishumo yenyaya yakatenderedza R & D yemishonga yechinyakare yeChinese, kugadzirira hunyanzvi, mirau nemitemo, kunaka uye kuchengetedzeka, optimization, michina mitsva, matekinoroji matsva, uye mamwe maindasitiri. Pharmaceuticals, semumwe wevanonyanya kuratidza chiitiko ichi, ine yakakosha dumba, iyo yakakwezva vazhinji vaaishanda navo muindasitiri kuti vashanyire! Munguva yemusangano, semumwe wevaratidziri vakakokwa, Enable Pharma aive nedumba rakakosha, iro rakakwezva vazhinji vevashandi veindasitiri kuti vashanyire dumba racho kuti vaone, kutaurirana kwepedyo nemakambani makuru emishonga, uye kudiwa kwekutsvagisa zvinodhaka nekusimudzira.
Nguva yekutumira: Jul-15-2023